Document:

Distributor
Agreement 

INNOVATIVE
LABORATORY SOLUTIONS, LLC

 

This Distributor
Agreement (the "Agreement") is made and effective this day of February 18, 2016, by and between Innovative
Laboratory Solutions, LLC, whose main office is located at 1900 Purdy Avenue, #5, Miami Beach, FL 33139, ("ILS"),
and iHealthcare, Inc., whose principle office is located at: 141 NE 3rd Avenue, 9th Floor, Miami, FL, 33132
(“Distributor”). Both ILS and Distributor may be collectively referred as the “Parties".

WHEREAS,

		·	ILS provides Drugs
of Abuse cups and other items for use in substance abuse treatment.

 

		·	The Distributor is
in the healthcare business and wishes to sell and market certain products sold by ILS.

 

		·	The Distributor
wishes to obtain from ILS the right to market, sell and distribute these products pursuant to the terms and conditions
set forth in this Agreement.

 

·    
NOW, THEREFORE, in consideration of the mutual
covenants, promises and agreements herein contained, the parties agree as follows:

 

		1.	DEFINITIONS

As used in this Agreement, the following terms
shall have the following meanings:

 

1.1  
“Product” or “Products” shall
mean, collectively, certain products offered for sale by ILS, including but not limited to, specimen cups and other products or
medical devices. 

 

1.2  
“Documentation” shall mean, collectively,
instructions, and other written materials made available by ILS in printed or electronic format to assist in the use of the Products.

 

1.3  
“Customers” are purchasers of any Products
from Distributor who have paid for an order. 

 

1.4  
"Trademarks" includes ILS trademarks, service
marks, trade names, and service names.

 

		2.	APPOINTMENT

ILS hereby appoints Distributor,
and Distributor hereby accepts such appointment (the “Appointment”), as an independent, and preferred reseller
of the Products for ILS as set forth below:

 

Distribution Rights.
ILS hereby appoints and assigns to Distributor the authority to sell and distribute all Products as defined below.

 

3.PRICING, ORDERS, PAYMENTS & DELIVERY

 

		3.1	Pricing. 

Distributor shall have the right
to purchase 1-39,999 drug of abuse toxicology cups from ILS at $2.85USD.
Pricing for ILS Products purchased by Distributor at a quantity greater than 39,999
will be established by the parties in writing.

 

		3.2	Purchase Order. 

All order for products shall
be made pursuant to a written Purchase Order submitted by Distributor to ILS (“Purchase Order”), in the form designated
by ILS, and as amended from time to time at the sole discretion of ILS. The Purchase Order form which is currently acceptable to
ILS, is attached as Exhibit “B”. All Purchase Orders shall be made expressly subject to the terms and conditions of
this Agreement.

 

In no event shall any Purchase
Order contain terms or conditions that are contrary to this Agreement, add contain new terms and conditions to this Agreement,
or change the terms and conditions of this Agreement. If a Purchase Order violates the provisions in this section in any way, then:
(1) the portions of the Purchase Order that contain the violations are automatically null and void, and have no force and effect;
and (2) ILS has the right to refuse to process such Purchase Order, or to accept the Purchase Order and ignore the portions that
violate this section.

 

		3.3	Payment. 

Unless otherwise agreed to by
Distributor in writing, Distributor shall pay ILS for all Products as set forth below:

		a.	Payment in full. Distributor shall pay for the entire Order at the time of placement;
OR

		b.	Two Payments. Only in the event Delivery is effected at a freight shipper (as noted below),
then Distributor has the option to split payment of the Order into two payments as set forth below:

		1.	Fifty percent (50%) of the each Order total is due immediately upon placement of Order.

		2.	The remaining fifty percent (50%) of the each Order total is due before the Product is released
to Distributor or Distributor’s client.

 

All payments from Distributor to
ILS hereunder shall be in United States Dollars, and can be made via cash, money order, electronic wire transfer, or credit card.
Credit card processing fees are paid by the Distributor.

 

		3.4	Delivery. 

Each Order is deemed delivered
(“Delivered”) to Distributor as noted below:

		a.	Freight Shipper. ILS designates delivery at a freight shipper
as the preferred method of delivery. The Product in an Order is deemed Delivered to Distributor once all of the following have
occurred: (1) ILS gives the freight shipper authorization to release the Product in the Order to Distributor; and (2) the freight
shipper releases the Product in the Order to Distributor; or

		b.	Designated Location. The Product in an Order shall be deemed
Delivered once the Product arrives at the location designated by Distributor in the Purchase Order.

Delivery locations must be within the Contiguous United
States, Alaska or Hawaii. ILS shall bear the risk of delivery up until the delivery location. For delivery locations outside the
United States, the parties shall discuss and reach mutually beneficial terms on a case by case basis.

 

		3.5	Order Cancellation by ILS. 

ILS may cancel any Order placed by
Distributor and accepted by ILS, if Distributor fails to make any payment for the Product as provided in this Agreement.

 

4.OBLIGATIONS AND REPRESENTATIONS
OF DISTRIBUTOR

		4.1	Products - No Tampering or Re-licensing. 

Distributor will distribute the Medical
Products with all warranties, disclaimers and license agreements intact and not obscured, as provided from ILS. Distributor will
advise its Customers as to the nature and terms applicable to the Products.

 

		4.2	Technical Capability.

Distributor will have the technical
capability to enable it to demonstrate and explain in detail to its Customers the features and capabilities of the Products. From
time to time, ILS may impose reasonable training or certification requirements on Distributor in connection with the resale of
certain Products. If a certification is required by ILS in the future, after a reasonable period of time is given to Distributor
to obtain the certification, Distributor will be required to satisfy the requirement before future orders for such Products will
be accepted by ILS. Certification requirements will be supplied to Distributor in writing by ILS from time to time during the term
of this Agreement.

 

 

 

4.3 Distributor’s Obligations
and Covenants 

Distributor warrants and
agrees:

		a.	to focus efforts on providing management, supervision, training,
invoicing services, collection services, quality assurance, and monitor utilization in regard to the Products;

		b.	to conduct business in a manner that reflects favorably upon the
Products and their high quality image and reputation, and upon the reputation of ILS;

		c.	hire, train and employ at its place or places of business competent,
professional and ethical sales, technical and support personnel to sell and support products as required by the demands of the
market. 

		d.	stay current with respect to information concerning the Products
and, where appropriate, attend ILS training with respect to the Products;

		e.	maintain adequate levels of personnel and other facilities to assure
prompt handling of all inquiries, orders, shipments and limited post-sales support for the Products;

		f.	maintain, for demonstration purposes, adequate equipment and other
resources to properly demonstrate the Products;

		g.	to avoid illegal or misleading practices in regard to this Agreement
that are or might be detrimental to the Products, ILS or the public;

		h.	comply with all Federal and State healthcare laws, rules and regulations,
including but not limited to Stark, Anti-Kickback, False Claims Act, etc.;

		i.	avoid helping, aiding or assisting a Customer in any way to violate
any Federal and State healthcare laws, rules and regulations, including but not limited to Stark, Anti-Kickback, False Claims Act,
etc.; 

		j.	not to create and afterward publish or employ or cooperate in the
publication or employment of any misleading or deceptive advertising material. This provision does not apply to publications created
or provided by ILS; and

		k.	not to make representations, warranties or guarantees to its Customers
with respect to Product or the capabilities of the Products that are false, misleading or inconsistent with the literature distributed
by ILS, including all warranties and disclaimers contained in such literature. This provision does not apply to representations
created or provided to Distributor directly by ILS; 

		l.	to comply with any minimum sales volumes or quotas, if any, which
have been agreed to by the Parties and reduced to writing. Minimum sales volumes or quotas may be adjusted or amended by agreement
of the Parties at any time during the course of this Agreement. 

		m.	to comply with any minimum marketing efforts, which include a quarterly
promotion of ILS Products in any one or more of the following manners, including, but not limited to: Mailers, telemarketing, advertising,
press releases, other print ads, trade shows, speeches, presentations, etc. These promotional efforts will be in addition to any
promotional efforts undertaken in conjunction with ILS. The standard requirements are subject to change by mutual agreement of
the Parties and shall take effect 30 calendar days after such agreement is reached; and

		n.	to follow all of the following in regard to Marketing and Promotion
Efforts for the Products:

		1.	Promotion and Marketing: Distributor, at its expense and discretion,
will use its best efforts to promote the marketing and licensing of the Products to its Customers by utilizing commercially available
and acceptable means of marketing including, but not limited to, advertising, telemarketing, other direct mail campaigns, trade
shows, conventions, seminars, personal solicitation, demonstrations, and distribution of promotional materials, all in accordance
with this Agreement. 

 

Unless agreed to in advance by ILS,
Distributor will pay any and all costs and expenses related to attending trade shows, conventions and seminars, which it has chosen
to attend or take part in. ILS will at its own discretion and expense, determine whether to send representatives to assist the
Distributor in these marketing efforts.

 

		2.	Promotional Literature: Any promotional literature used by
Distributor in regard to the Products must meet all of Distributor’s responsibilities under this Agreement. Distributor cannot
develop or use any other product literature other than that provided by ILS without the written consent of ILS. 

 

		4.4	Distributor’s Financial Condition.

Distributor represents that, as of
the effective date of this Agreement, it is in sound financial condition.

 

		4.5	Product Packaging. 

The Distributor
may, with prior written approval of ILS, make changes to the product label (i.e., private label) for a client at an additional
cost to Distributor. Unless there is a legitimate business reason otherwise, ILS will typically approve the custom packaging of
any product provided that the following requirements are met:

		a.	The requested change is in the interest of ILS;

		b.	The requested change does not cause harm to any of ILS’ business trademarks, patents or
other intellectual property;

		c.	The requested change does not violation any trademark, patent or other intellectual property
right of another entity; and

		d.	The requested change complies with all applicable FDA laws and rules. 

 

 

		5.	ILS’S OBLIGATIONS

		5.1	ILS Obligations and Covenants. 

ILS warrants and agrees:

		a.	to cooperate and promptly provide true and accurate specifications,
details or other information to Distributor for use by Distributor as part of its marketing, promotional or compliance activities
of ILS Products;

		b.	to process and deliver all Orders for the Products received from
Distributor in a timely manner; 

		c.	to take diligent care to pack the products in the most secure fashion
possible to insure best protection of the products. 

		d.	that all Orders of the Products sold or shipped under this Agreement
shall be of first quality, without any defects and in full conformity with all applicable laws, regulations and requirements in
effect within the Territory; and

		e.	to assist Distributor with its efforts to set up any training or
certification requirements set forth by ILS.

		f.	ILS shall utilize it best efforts to have manufacturer replace any
damaged products which occurred prior to receipt of Products by Distributor, however occurred. 

 

6. Force Majure.

The Parties shall not be responsible for any
failure to perform due to unforeseen circumstances or to causes beyond the Parties control, including but not limited to acts of
God, war, riot embargoes, and acts of civil or military authorities, fire, floods, accidents, strikes, or shortages of transportation,
facilities, fuel, energy, labor or materials. In the event of any such delay, ILS may defer the delivery date of orders for the
Products for a period equal to the time of such delay. ILS shall not be liable for any damages, direct, consequential, special,
or otherwise, to Distributor or to any other person for failure to deliver or for any delay or error in delivery of the products
for any reason whatsoever.

 

7. DISCLAIMER.

Except as explicitly set forth in writing in
this Agreement, ILS makes no additional performance representations, warranties, or guarantees, either express or implied, oral
or written, with respect to ILS Products or any services covered by or furnished pursuant to this Agreement.

 

		8.	INTELLECTUAL PROPERTY.

		8.1	Limited Rights.

By performance of this agreement,
Distributor shall not acquire any right to any of ILS Trademarks, or its copyrights, patents, trade secrets, commercial symbols,
goodwill, or other form of its intellectual or commercial property. Distributor shall use ILS’s trademarks only as set forth
in this Agreement. ILS may from time to time discontinue or modify its Trademarks, add new Trademarks, and revise these instructions,
or those set forth elsewhere in this Agreement, to protect the standards of quality established for ILS goods and services marketed
and/or licensed under its Trademarks. It is expressly understood by ILS that Distributor develops software, including but not limited
to Medical Devices and Operating Systems, which may be considered competitive to ILS.

 

		8.2	Protection of Trademarks.

ILS shall have sole and exclusive
right to protect and defend the Trademarks, at its sole cost and expense. ILS shall not be liable to Distributor for any loss or
damage suffered by Distributor as a result of the use of the Trademarks, any litigation or proceeding involving the Trademarks
or any failure by ILS to protect or defend the Trademarks.

 

		9.	CONFIDENTIAL INFORMATION

		9.1	Confidential Information.

As used herein, "Confidential
Information" shall mean all information concerning either party (the "Disclosing Party") to which the other party
(the "Receiving Party") is provided access by virtue of this Agreement or its activities hereunder, including without
limitation source code, technical data, sales information, quantity and kind of ILS Products or Distributor Products marketed or
sold, prices and methods of pricing, marketing techniques and plans, returns, unannounced products, product and process information,
and such other information which, if disclosed to others, might be competitively detrimental to the Disclosing Party. Confidential
Information shall not include any information which has been publicly disseminated in writing by the Disclosing Party, which the
Receiving Party can show it knew prior to the Disclosing Party's disclosure hereunder, or which is rightfully received by the Receiving
Party from a third party without restriction.

During the term of this Agreement
and for five (5) years thereafter, the Receiving Party shall maintain the Confidential Information of the Disclosing Party in strictest
confidence, shall not disclose it to any third party, and shall use it only as necessary to perform hereunder. The Receiving Party
shall cause each of its officers, directors, employees, and agents to restrict disclosure and use of such Confidential Information
in like fashion, and shall be responsible for any wrongful disclosure or use by any of them.

In the event any court or other
authority orders the Receiving Party to disclose any Confidential Information of the Disclosing Party, the Receiving Party shall
use its best efforts to protect its confidentiality and shall forthwith notify the Disclosing Party thereof to enable it to do
likewise. At the termination of this Agreement, the Receiving Party shall promptly return all tangible Confidential Information
to the Disclosing Party.

 

		9.2	Nondisclosure and Nonuse of Confidential Information.

Distributor acknowledges that: (i)
the Confidential Information is a valuable, special, and unique asset of ILS, the unauthorized disclosure or use of which could
cause substantial injury and loss of profits and goodwill to ILS; (ii) Distributor is in a position of trust and subject to a duty
of loyalty to ILS, and (iii) by reason of this Agreement, Distributor will have access to the Confidential Information. Distributor,
therefore, acknowledges that it is in ILS’s legitimate business interest to restrict Distributor’s disclosure or use
of Confidential Information for any purpose other than in connection with Distributor’s performance of Distributor’s
duties for ILS, and to limit any potential misappropriation of such Confidential Information by Distributor.

 

Distributor will not disclose or
use at any time, either during the term of this Agreement or thereafter, any Confidential Information (as hereinafter defined)
of which Distributor is or becomes aware, whether or not such information is developed by him or her, except to the extent that
such disclosure or use is directly related to and required by Distributor’s performance in good faith of duties assigned
to Distributor by ILS; provided, however, that this sentence shall not be deemed to prohibit Distributor from complying with any
subpoena, order, judgment, or decree of a court or governmental or regulatory agency of competent jurisdiction (an “Order”).
In the event there is an Order: (i) Distributor agrees to provide ILS with prompt written notice of any such Order and to assist
ILS, at ILS’s expense, in asserting any legal challenges to or appeals of such Order that ILS in its sole discretion pursues,
and (ii) in complying with any such Order, Distributor shall limit his or her disclosure only to the Confidential Information that
is expressly required to be disclosed by such Order. Distributor will take all appropriate steps to safeguard Confidential Information
and to protect it against disclosure, misuse, espionage, loss, and theft. Distributor shall deliver to ILS at the Termination Date,
or at any time ILS may request, all memoranda, notes, plans, records, reports, electronic information, files and software, and
other documents and data (and copies thereof) relating to the Confidential Information or the Work Product (as hereinafter defined)
of the business of ILS which Distributor may then possess or have under his or her control.

 

9.
3 NONCIRCUMVENTION
AND NONSOLICIATION 

 

Both parties acknowledge they will be selling
directly to retail customers of urine specimen cups in the United States. In addition, iHealthcare intends to develop other Channel
Partners in Europe, Russia, Caribbean and Latin America. The parties expressly agree to offer, honor and respect such sales as
exclusive market rights to customers or channel partners developed and sold to in the territory by each respective party. Neither
party shall attempt to solicit or interfere with or divert business from the other party’s customers or channel partners
at any time. In the event of sales or channel conflicts which may inadvertently develop, the parties agree to work together in
good faith to establish a mutually beneficial solution. A customer is defined by a paid sales order.

 

Further, Distributor will notify ILS in writing
of approved Channel Partners as agreements are signed. Once so registered with ILS, ILS agrees to not circumvent such agreements,
nor solicit such Channel Partners or their customers and automatically extends exclusive market rights to iHealthcare for such
Channel Partner arrangements. In the event that ILS is contacted directly by a current Channel Partner or customer of a Channel
Partner or customer of iHealthcare, ILS will use its best efforts to notify iHealthcare of the contact and refer the Channel Partner
or customer back to iHealthcare to process orders. ILS shall not offer pricing nor accept orders from or with an iHeathcare Channel
Partner or any or any Channel Partner customer or any iHealthcare customer that have not been properly placed and processed through
iHealthcare.

 

In the event that a prospective Channel Partner
or customer contacts both parties before an agreement is signed, the parties agree that the party to have made first contact will
have first rights of refusal to enter into an agreement. In the event a Channel Partner opportunity arises from retail customers
both parties have as customers, iHealthcare shall have the right of first refusal to sign a Channel Partner agreement should a
Channel Partner opportunity arise from those retail opportunities. In the event that both parties are selling to retail entities
of a new Channel Partner before a Channel Partner agreement is signed, the parties shall work together to ensure a mutually beneficial
solution protecting the business interests and value already developed by each party, to the extent possible.

 

10. MUTUAL HOLD HARMLESS AND INDEMNIFICATION.

Each Party shall defend, indemnify and hold
the other Party, its affiliated companies, shareholders, officers, directors, Board Members, agents, and employees harmless from
any and all claims by any other party (including reasonable attorneys' fees and costs of litigation) resulting from, but not limited
to, each Party’s [of this agreement] errors, acts, omissions or misrepresentations. This includes, but is not limited to:

 

		a.	relating to Distributor's combining (or its authorizing others to
combine) the ILS Products with any products not provided by ILS, or

		b.	relating to Distributor’s marketing or distribution of the
Products, subject to the following exception, that ILS had no part or responsibility in either creating, assisting, or providing
information or direction related to the marketing and distribution giving rise to the third party claim or cause of action.

 

Each Party shall also defend, indemnify and hold harmless the other
Party and its directors, officers, agents and employees against any and all loss, liability, damage, or expense, liability, damage,
or expense, but not including attorneys’ fees unless awarded by a court of competent jurisdiction, for injury or death to
persons, including employees of either Party, and damage to property, including property of either Party, arising out of or in
connection with intentional, willful, or wanton, conduct regarding, but not limited to:

 

		a.	the engineering, design, construction, maintenance, or repair of ILS’s products. 

 

		11.	LIMITATION OF LIABILITY.

EXCEPT AS EXPRESSLY PROVIDED TO THE CONTRARY
IN SECTION 10, IN NO EVENT SHALL ILS, ITS MEMBERS, EMPLOYEES, ASSIGNS OR AFFILIATED ENTITIES BE LIABLE TO DISTRIBUTOR OR ANY THIRD
PARTY FOR INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES NEGLIGENTLY CAUSED.

 

		12.	TERM AND TERMINATION.

		12.1	Initial Term. 

This Agreement shall take effect
upon full execution of the Agreement by both Parties (the “Effective Date”), and continue for an initial term of three
(3) years (the "INITIAL TERM").

 

 

		12.2	Renewal Term. 

This Agreement shall automatically
renew for additional consecutive one (1) year terms (the “Renewal Terms”) unless either Party gives the other Party
prior written notification of its intent to let this Agreement expire. This notice must be delivered no less than forty-five (45)
calendar days before such expiration of the then current Term, otherwise the Agreement shall renew for an additional Renewal Term.

 

		12.3	Termination for Cause.

		a.	Either party will have the right to terminate this Agreement at any
time if the other party is in breach of any material term, and which such party fails to cure within 10 calendar day after receiving
written notice of the breach and the party’s intention to terminate. 

 

		b.	ILS shall have the right to terminate this Agreement if Distributor:

		1.	becomes insolvent;

		2.	discontinues its business; or

		3.	becomes the subject of any voluntary or involuntary proceeding in
bankruptcy, liquidation, dissolution, receivership, attachment or composition for the benefit of creditors. 

 

Such termination will become effective
upon the non-terminating party’s receipt of a notice of termination at any time after the specified event.

 

		12.4	Effect of Termination.

Upon termination or expiration of
this Agreement:

		a.	ILS may, at its option,

		1.	cancel any non-final orders prior to shipment and refund to Distributor
all related payments made in connection therewith, or

		2.	keep all amounts paid by Distributor to ILS and provide the Products
to Customers. 

 

After termination notices, the due
dates of all outstanding invoices to Distributor for the Products will be accelerated so they become due and payable on the effective
date of the termination or expiration, even if longer terms had been previously provided. Notwithstanding any credit terms made
available to Distributor prior to such notice, any Products ordered thereafter shall be paid for by certified or cashier’s
check prior to activation.

		b.	Distributor shall cease using any ILS trademark, logo or trade name
and Distributor’s right to market and license any Products shall automatically terminate.

 

		c.	Distributor’s obligations to pay ILS all amounts due hereunder,
as well as either party’s obligations relating to indemnification, warranties, disclaimers or warranty, protection of proprietary
rights and confidential information shall survive termination of this Agreement.

 

		d.	The Non-Circumvention Section 9.3 shall remain in full force and
effect post termination or expiration. ILS shall continue to honor sales agreements and recurring orders and terms in place made
and developed by iHealthcare for customers and channel partners, provided customers and channel partners honor the payment terms
of this agreement. 

		13.	COMPLIANCE WITH LAWS.

13.1
Compliance with Healthcare Laws, including “Kickback” Laws.

		a.	"Kickback" as used in this clause
means any illegal remuneration, money, fee, commission, credit, gift, gratuity, thing of value, or compensation of any kind which
is provided, directly or indirectly, for any designated health services for the purpose of improperly obtaining or rewarding referrals
for items or services reimbursable by any Federal or State health care program, or in violation of any State of Federal laws. 

		b.	The Parties agree to comply with all State & Federal healthcare
rules and regulations, as well as any laws, rules or regulations in any of the other jurisdictions in the Territory, including
but not limited to any “Kickback” laws, such as Stark, Anti-Kickback and Florida’s Patient Self-Referral Act
of 1992. 

		c.	Distributor will set up a compliance program to ensure that it maintains
compliance with these healthcare provisions throughout the term of this Agreement. At a minimum, each year the parties will get
together and review their business operations to ensure they are in compliance with all laws, rules and regulations governing the
sale or distribution of the Products and the processes and procedures beings used by ILS or Distributor.

		d.	The parties agree to use their best efforts to immediately and remedy
any actions or obligations that they find may arguably be a current violation or a future violation, including making any contractual
amendments to incorporate such changes. However, since the goal of the Parties is to always maintain compliance in all current
and future activity, any change made pursuant to these provisions shall not establish or imply that the change was in fact a violation.

 

13.2 Compliance with other Laws.

 

ILS acknowledges that it is responsible
for complying with all governmental laws, ordinances, rules and regulations in the United States ("Laws"), including
without limitation all Laws which may govern (I) the importation, exportation, transportation, storage, marketing of Products in
the Territory, and Government permits or approvals, compliance with customs requirements or testing of any Products. ILS shall
cooperate fully with Distributor in complying with any governmental agency order or rule.

 

Distributor acknowledges that it
is responsible for complying with all governmental laws, ordinances, rules and regulations of the Territory outside the United
States ("Laws"), including without limitation all Laws which may govern (I) the importation, exportation, transportation,
storage, marketing, distribution, sale, use and disposal of Products in the Territory, and Government permits or approvals, compliance
with customs requirements or testing of any Products. ILS shall cooperate fully with Distributor in complying with any governmental
agency order or rule. Distributor shall take all actions and precautions to put into place contractual obligations requiring its
Customer or Channel partners to comply with such laws or regulations as well.

 

14. MISCELLANEOUS PROVISIONS

		14.1	Independent Contractors.

The relationship of ILS and Distributor
established by this Agreement is that of independent contractors. This Agreement does not give either party the power to direct
and control the day to day activities of the other or otherwise participants in a joint or common undertaking, or allow either
party to create or assume any obligation on behalf of the other party for any purpose whatsoever.

 

		14.2	Amendments and Modifications of Terms.

This Agreement
may only be modified or amended upon mutual written agreement signed by authorized representatives of the parties. No oral agreements
or representations made after the Effective Date shall be valid or binding upon the parties unless they comply with the requirements
of this paragraph.

 

Furthermore,
the parties agree that at any time during this Agreement, they will cooperate with and shall not to unreasonably withhold consent,
to amending or changing portions of the Agreement when the amendment or change is necessary or reasonable to facilitate either
party's compliance with any law or regulation, including those in a particular Territory.

 

Notwithstanding
the foregoing, ILS is not permitted to: (i) change the location or size of any Territory; (ii) charge any additional fees or costs
whatsoever to Distributor other than those set forth herein, except as specifically authorized by this Agreement; or (iii) require
Distributor to execute any additional agreements, amendments to this Agreement, or to follow any guidelines or rules that are materially
different than the most current form of distribution agreement as it exists upon the Effective Date and as utilized by Distributor
in North, South and Central America and Caribbean Basin.

 

		14.3	Waiver. 

The delay or failure by a party
to exercise or enforce any of its rights under this Agreement shall not constitute or be deemed a waiver of the party’s right
thereafter to enforce those rights, nor shall any single or partial exercise of any such right preclude any other or further exercise
thereof or the exercise of any other right.

 

		14.4	Governing Law.

This Agreement shall be governed
by and construed in accordance with the laws of the State of Florida, U.S.A., and the venue for any arbitration or litigation concerning
this Agreement shall be in Miami Dade County, Florida. Distributor consents to the jurisdiction in Miami Dade County, Florida.

 

		14.5	Dispute Resolution.

Prior to commencing any litigation
or other legal or equitable formal action, the Parties may jointly decide to submit the dispute to non-binding mediation, where
the parties will share equally all mediation fees.

 

		14.6  Notices.	

All notices and other communications
hereunder shall be given in writing and delivered (a) by personal delivery, by prepaid overnight or courier service to the addresses
set forth herein, or (b) by facsimile to such facsimile number as may be provided in writing by a party.

 

Notices are deemed given on receipt
or attempted delivery (if receipt is refused).All notices, consents, waivers or other communications given hereunder shall be in
writing, shall be delivered by hand, by registered or certified post (return receipt requested) or sent by facsimile, and shall
be deemed received upon actual delivery. All notices shall be directed as follows with a copy to such other person as either Party
may from time to time nominate:

 

To: ILSTo: Distributor

Carlos LeonNoel Mijares

1900 Purdy Avenue, #5141
NE 3rd Avenue, 9th Floor

Miami Beach, FL 33139Miami,
FL 33132

Fax. 305.671.3507305-336-5608

Toll Free 1.800.615.0266nmijares@ihealthcaresystems.com

carlos@inodetox.com Email Address

 

		14.7	Assignment / Subcontracting.

Distributor may not assign or subcontract
its rights or obligations without first obtaining the written permission of ILS, which such permission will not be unreasonably
withheld or delayed. Distributor has an affirmative obligation to disclose the existence of this Exclusive Distribution Agreement
to any bona fide entity looking to purchase the rights to the PRODUCTS or purchase Distributor or a majority ownership of its voting
shares (whatever would constitute a majority at the time of the inquiry). Furthermore, any such purchase, assumption, or sale of
Distributor of the PRODUCTS, in whole or part, must be expressly subject to the terms of this Agreement.

 

		14.8	Attorney’s Fees.

In the event of any litigation or
arbitration hereunder, the arbitrator or court shall award costs and reasonable attorneys' fees to the prevailing party.

		14.9	Severability.

The terms of this Agreement are
severable. If any term hereof is held invalid, illegal, or unenforceable for any reason whatsoever, such term shall be enforced
to the fullest extent permitted by applicable law, and the validity, legality, and enforceability of the remaining terms shall
not in any way be affected or impaired thereby.

 

    	 

    	 

    

 

Exhibit Listing:

 

The following Exhibits are attached to and made part
of this Agreement:

 

	Exhibit	Description
	A	Purchase Order Form
	 	 
	 	 

 

 

 

*****

REMAINDER OF PAGE INTENTIONALLY BLANK

SIGNATURE PAGE FOLLOWS

*****

    	 

    	 

    

 

IN WITNESS WHEREOF, this Agreement
has been duly executed by authorized representative of Main Avenue Pharmacy.

 

 

 

Innovative
Laboratory Services, LLC

	
         

         

        //Carlos Leon//

         
	 
	
         

        Signature

         

	
        BY: Carlos
        Leon

         

        ITS: Managing
        Member

	 
	
        02/18/2016

        Date
        Signed

	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 	 

 

 

 

 

    	 

    	 

    

 

IN WITNESS WHEREOF, this Agreement
has been duly executed as an authorized representative of Distributor.

	
         

         

        Distributor

         

         

        //Noel Mijares//

	
         

        Signature

         

	
        BY: Noel
        mijares

         

        ITS:
        Chief Executive officer

	 
	
        02/18/2016

        Date
        Signed

 

 

 

 

 

 

    	 

    	 

    

 

 

 

 

ILS
Purchase order form

 Exhibit “A”

 

 

 

 

 

 

    	 

    	 

    

 

 

 

 

	
        Purchase Order

 

                                                    
Bank Info.

innovative
laboratory solutions

Regions
Bank

Routing
#063104668

Acct #0198074121

 

 

	
        Additional Notes:

        This Purchase Order is made subject to the written Distributor Agreement
        between ILS and Distributor. No changes, alterations, modifications or additions to the Distributor Agreement may be made on this
        Purchase Order.

        ·       
        No Sales Tax on out-of-state sales

        ·       
        FOB Miami OEM Ocean Freight.Exhibit

12

Counterpart     of 70

Exhibit 4.33

ENTERGY LOUISIANA, LLC
(successor to Entergy Louisiana, LLC)

TO

THE BANK OF NEW YORK MELLON
(successor to The Chase National Bank of the City of New York)

As Trustee under Entergy Louisiana, LLC’s Mortgage and Deed of Trust 
dated as of April 1, 1944

________________

Eighty-sixth Supplemental Indenture

Providing among other things for

First Mortgage Bonds, 4.875% Series due September 1, 2066
(Ninetieth Series)

Dated as of August 1, 2016

EIGHTY-SIXTH SUPPLEMENTAL INDENTURE
Indenture, dated as of August 1, 2016, between ENTERGY LOUISIANA, LLC, a limited liability company of the State of Texas (formerly Entergy Louisiana Power, LLC and hereinafter sometimes called the “Company”), as successor to ENTERGY LOUISIANA, LLC, a limited liability company of the State of Texas organized on December 31, 2005 (hereinafter sometimes called the “Predecessor Company”), successor to ENTERGY LOUISIANA, INC., a corporation of the State of Louisiana converted to a corporation of the State of Texas on December 31, 2005 (hereinafter sometimes called the “Louisiana Company”), which was the successor by merger to LOUISIANA POWER & LIGHT COMPANY, a corporation of the State of Florida (hereinafter sometimes called the “Florida Company”), whose post office address is 4809 Jefferson Highway, Jefferson, Louisiana 70121, and THE BANK OF NEW YORK MELLON, a New York banking corporation (successor to THE CHASE NATIONAL BANK OF THE CITY OF NEW YORK) whose principal corporate trust office is located at 101 Barclay Street, New York, New York 10286 (hereinafter sometimes called “Trustee”), as Trustee under the Mortgage and Deed of Trust, dated as of April 1, 1944 (hereinafter called the “Mortgage”), which Mortgage was executed and delivered by the Florida Company to secure the payment of bonds issued or to be issued under and in accordance with the provisions of the Mortgage, reference to which Mortgage is hereby made, this Indenture (hereinafter called the “Eighty-sixth Supplemental Indenture”) being supplemental thereto;
WHEREAS, the Mortgage was recorded in various Parishes in the State of Louisiana, which Parishes are the same Parishes in which this Eighty-sixth Supplemental Indenture is to be recorded; and
WHEREAS, by the Mortgage, the Florida Company covenanted that it would execute and deliver such supplemental indenture or indentures and such further instruments and do such further acts as might be necessary or proper to carry out more effectually the purposes of the Mortgage and to make subject to the lien of the Mortgage any property thereafter acquired and intended to be subject to the lien thereof; and
WHEREAS, the Florida Company executed and delivered the following supplemental indentures:

	
		
	Designation
	Dated as of

	First Supplemental Indenture 
	March 1, 1948

	Second Supplemental Indenture 
	November 1, 1950

	Third Supplemental Indenture 
	September 1, 1953

	Fourth Supplemental Indenture 
	October 1, 1954

	Fifth Supplemental Indenture 
	January 1, 1957

	Sixth Supplemental Indenture 
	April 1, 1960

	Seventh Supplemental Indenture 
	June 1, 1964

	Eighth Supplemental Indenture 
	March 1, 1966

	Ninth Supplemental Indenture 
	February 1, 1967

	Tenth Supplemental Indenture 
	September 1, 1967

	Eleventh Supplemental Indenture 
	March 1, 1968

	Twelfth Supplemental Indenture 
	June 1, 1969

	Thirteenth Supplemental Indenture 
	December 1, 1969

	Fourteenth Supplemental Indenture 
	November 1, 1970

	Fifteenth Supplemental Indenture 
	April 1, 1971

	Sixteenth Supplemental Indenture 
	January 1, 1972

	Seventeenth Supplemental Indenture 
	November 1, 1972

	Eighteenth Supplemental Indenture 
	June 1, 1973

	Nineteenth Supplemental Indenture 
	March 1, 1974

	Twentieth Supplemental Indenture 
	November 1, 1974

	 
	 

which supplemental indentures were recorded in various Parishes in the State of Louisiana; and
WHEREAS, the Florida Company was merged into the Louisiana Company on February 28, 1975, and the Louisiana Company thereupon executed and delivered a Twenty-first Supplemental Indenture, dated as of March 1, 1975, pursuant to which the Louisiana Company, among other things, assumed and agreed duly and punctually to pay the principal of and interest on the bonds at the time issued and outstanding under the Mortgage, as then supplemented, in accordance with the provisions of said bonds and of any appurtenant coupons and of the Mortgage as so supplemented, and duly and punctually to observe, perform and fulfill all of the covenants and conditions of the Mortgage, as so supplemented, to be kept or performed by the Florida Company, and said Twenty-first Supplemental Indenture was recorded in various Parishes in the State of Louisiana; and
WHEREAS, the Louisiana Company succeeded to and was substituted for the Florida Company under the Mortgage with the same effect as if it had been named as mortgagor corporation therein; and
WHEREAS, the Louisiana Company executed and delivered the following supplemental indentures:

	
		
	Designation
	Dated as of

	Twenty-second Supplemental Indenture 
	September 1, 1975

	Twenty-third Supplemental Indenture 
	December 1, 1976

	Twenty-fourth Supplemental Indenture 
	January 1, 1978

	Twenty-fifth Supplemental Indenture 
	July 1, 1978

	Twenty-sixth Supplemental Indenture 
	May 1, 1979

	Twenty-seventh Supplemental Indenture 
	November 1, 1979

	Twenty-eighth Supplemental Indenture 
	December 1, 1980

	Twenty-ninth Supplemental Indenture 
	April 1, 1981

	Thirtieth Supplemental Indenture 
	December 1, 1981

	Thirty-first Supplemental Indenture 
	March 1, 1983

	Thirty-second Supplemental Indenture 
	September 1, 1983

	Thirty-third Supplemental Indenture 
	August 1, 1984

	Thirty-fourth Supplemental Indenture 
	November 1, 1984

	Thirty-fifth Supplemental Indenture 
	December 1, 1984

	Thirty-sixth Supplemental Indenture 
	December 1, 1985

	Thirty-seventh Supplemental Indenture 
	April 1, 1986

	Thirty-eighth Supplemental Indenture 
	November 1, 1986

	Thirty-ninth Supplemental Indenture 
	May 1, 1988

	Fortieth Supplemental Indenture 
	December 1, 1988

	Forty-first Supplemental Indenture 
	April 1, 1990

	Forty-second Supplemental Indenture 
	June 1, 1991

	Forty-third Supplemental Indenture 
	April 1, 1992

	Forty-fourth Supplemental Indenture 
	July 1, 1992

	Forty-fifth Supplemental Indenture 
	December 1, 1992

	Forty-sixth Supplemental Indenture 
	March 1, 1993

	Forty-seventh Supplemental Indenture 
	May 1, 1993

	Forty-eighth Supplemental Indenture 
	December 1, 1993

	Forty-ninth Supplemental Indenture 
	July 1, 1994

	Fiftieth Supplemental Indenture 
	September 1, 1994

	Fifty-first Supplemental Indenture 
	March 1, 1996

	Fifty-second Supplemental Indenture 
	March 1, 1998

	Fifty-third Supplemental Indenture 
	March 1, 1999

	Fifty-fourth Supplemental Indenture 
	June 1, 1999

	Fifty-fifth Supplemental Indenture 
	May 15, 2000

	Fifty-sixth Supplemental Indenture
	March 1, 2002

	Fifty-seventh Supplemental Indenture
	March 1, 2004

	Fifty-eighth Supplemental Indenture 
	October 1, 2004

	Fifty-ninth Supplemental Indenture
	October 15, 2004

	Sixtieth Supplemental Indenture 
	May 1, 2005

	Sixty-first Supplemental Indenture 
	August 1, 2005

	Sixty-second Supplemental Indenture 
	October 1, 2005

	Sixty-third Supplemental Indenture 
	December 15, 2005

	 
	 

which supplemental indentures were recorded in various Parishes in the State of Louisiana; and
WHEREAS, the Louisiana Company converted into a Texas limited liability company and, pursuant to a Plan of Merger by which the Company and Entergy Louisiana Properties, LLC were created (the “Merger Documents”), underwent a merger by division pursuant to which, among other things, all the Mortgaged and Pledged Property, subject to the Lien of the Mortgage, and all of the rights, obligations and duties of the 

Louisiana Company under the Mortgage, were allocated to the Predecessor Company on December 31, 2005, and the Predecessor Company thereupon executed and delivered a Sixty-fourth Supplemental Indenture, effective as of January 1, 2006, pursuant to which the Predecessor Company, among other things, assumed and agreed duly and punctually to pay the principal of and interest on the bonds at the time issued and outstanding under the Mortgage, as then supplemented, in accordance with the provisions of said bonds and of any appurtenant coupons and of the Mortgage as so supplemented, and duly and punctually to observe, perform and fulfill all of the covenants and conditions of the Mortgage, as so supplemented, to be kept or performed by the Louisiana Company, and said Sixty-fourth Supplemental Indenture was recorded in various Parishes in the State of Louisiana and with the Secretary of State of Texas; and
WHEREAS, effective July 1, 2008, The Bank of New York changed its name to The Bank of New York Mellon; and
WHEREAS, the Predecessor Company executed and delivered the following supplemental indentures:
	
		
	Designation
	Dated as of

	Sixty-fifth Supplemental Indenture 
	August 1, 2008

	Sixty-sixth Supplemental Indenture
	November 1, 2009

	Sixty-seventh Supplemental Indenture
	March 1, 2010

	Sixty-eighth Supplemental Indenture
	September 1, 2010

	Sixty-ninth Supplemental Indenture
	October 1, 2010

	Seventieth Supplemental Indenture
	November 1, 2010

	Seventy-first Supplemental Indenture
	March 1, 2011

	Seventy-second Supplemental Indenture
	April 30, 2011

	Seventy-third Supplemental Indenture
	December 1, 2011

	Seventy-fourth Supplemental Indenture
	January 1, 2012

	Seventy-fifth Supplemental Indenture
	July 1, 2012

	Seventy-sixth Supplemental Indenture
	December 1, 2012

	Seventy-seventh Supplemental Indenture
	May 1, 2013

	Seventy-eighth Supplemental Indenture
	August 1, 2013

	Seventy-ninth Supplemental Indenture
	June 1, 2014

	Eightieth Supplemental Indenture
	July 1, 2014

	Eighty-first Supplemental Indenture
	November 1, 2014

	 
	 

which supplemental indentures were recorded in various Parishes in the State of Louisiana and with the Secretary of State of Texas; and
WHEREAS, effective as of 10:03 A.M. Central Time, October 1, 2015, the Predecessor Company transferred, subject to the Lien of the Mortgage, all or substantially all of the Mortgaged and Pledged Property as an entirety to the Company (the “2015 Transfer”) pursuant to a Plan of Merger between the Predecessor Company and the Company (the “2015 Transfer Documents”), pursuant to which, among other things, the Company succeeded to the ownership of all of the Predecessor Company’s right, title and interest in and to the Mortgaged and Pledged Property as constituted immediately prior to the time that the 2015 Transfer became effective and succeeded to all of the Predecessor Company’s duties and obligations under the Mortgage and the bonds outstanding thereunder;  and 
WHEREAS, upon the 2015 Transfer, the Predecessor Company was released and discharged from all obligations under the Mortgage or any bonds issued thereunder; and

WHEREAS, effective as of 2:02 P.M. Central Time, October 1, 2015, the Company changed its name from “Entergy Louisiana Power, LLC” to “Entergy Louisiana, LLC”;
WHEREAS, the Company executed and delivered an Eighty-second Supplemental Indenture, effective as of October 1, 2015, pursuant to which the Company, among other things, assumed and agreed duly and punctually to pay the principal of and interest on the bonds at the time issued and outstanding under the Mortgage, as then supplemented, in accordance with the provisions of said bonds and of any appurtenant coupons and of the Mortgage as so supplemented, and duly and punctually to observe, perform and fulfill all of the covenants and conditions of the Mortgage, as so supplemented, to be kept or performed by the Predecessor Company thereunder, and said Eighty-second Supplemental Indenture was recorded in various Parishes in the State of Louisiana and with the Secretary of State of Texas; and
WHEREAS, the Company executed and delivered the following supplemental indentures:
	
		
	Designation
	Dated as of

	Eighty-third Supplemental Indenture 
	March 15, 2016

	Eighty-fourth Supplemental Indenture
	March 17, 2016

	Eighty-fifth Supplemental Indenture
	March 17, 2016

which supplemental indentures were recorded in various Parishes in the State of Louisiana and with the Secretary of State of Texas; and
WHEREAS, in addition to the property described in the Mortgage, as supplemented, the Company has acquired certain other property, rights and interests in property; and
WHEREAS, the Florida Company, the Louisiana Company or the Predecessor Company has heretofore issued, in accordance with the provisions of the Mortgage, as supplemented, the following series of bonds:
	
			
	Series
	Principal
Amount
Issued
	Principal
Amount
Outstanding

	3% Series due 1974 
	$ 17,000,000
	None

	3 1/8% Series due 1978 
	10,000,000
	None

	3% Series due 1980 
	10,000,000
	None

	4% Series due 1983 
	12,000,000
	None

	3 1/8% Series due 1984 
	18,000,000
	None

	4 3/4% Series due 1987 
	20,000,000
	None

	5% Series due 1990 
	20,000,000
	None

	4 5/8% Series due 1994 
	25,000,000
	None

	5 3/4% Series due 1996 
	35,000,000
	None

	5 5/8% Series due 1997 
	16,000,000
	None

	6 1/2% Series due September 1, 1997 
	18,000,000
	None

	7 1/8% Series due 1998 
	35,000,000
	None

	9 3/8% Series due 1999 
	25,000,000
	None

	9 3/8% Series due 2000 
	20,000,000
	None

	7 7/8% Series due 2001 
	25,000,000
	None

	7 1/2% Series due 2002 
	25,000,000
	None

	7 1/2% Series due November 1, 2002 
	25,000,000
	None

	8% Series due 2003 
	45,000,000
	None

	
			
	8 3/4% Series due 2004 
	45,000,000
	None

	9 1/2% Series due November 1, 1981 
	50,000,000
	None

	9 3/8% Series due September 1, 1983 
	50,000,000
	None

	8 3/4% Series due December 1, 2006 
	40,000,000
	None

	9% Series due January 1, 1986 
	75,000,000
	None

	10% Series due July 1, 2008 
	60,000,000
	None

	10 7/8% Series due May 1, 1989 
	45,000,000
	None

	13 1/2% Series due November 1, 2009 
	55,000,000
	None

	15 3/4% Series due December 1, 1988 
	50,000,000
	None

	16% Series due April 1, 1991 
	75,000,000
	None

	16 1/4% Series due December 1, 1991 
	100,000,000
	None

	12% Series due March 1, 1993 
	100,000,000
	None

	13 1/4% Series due March 1, 2013 
	100,000,000
	None

	13% Series due September 1, 2013 
	50,000,000
	None

	16% Series due August 1, 1994 
	100,000,000
	None

	14 3/4% Series due November 1, 2014 
	55,000,000
	None

	15 1/4% Series due December 1, 2014 
	35,000,000
	None

	14% Series due December 1, 1992 
	60,000,000
	None

	14 1/4% Series due December 1, 1995 
	15,000,000
	None

	10 1/2% Series due April 1, 1993 
	200,000,000
	None

	10 3/8% Series due November 1, 2016 
	280,000,000
	None

	Series 1988A due September 30, 1988 
	13,334,000
	None

	Series 1988B due September 30, 1988 
	10,000,000
	None

	Series 1988C due September 30, 1988 
	6,667,000
	None

	10.36% Series due December 1, 1995 
	75,000,000
	None

	10 1/8% Series due April 1, 2020 
	100,000,000
	None

	Environmental Series A due June 1, 2021 
	52,500,000
	None

	Environmental Series B due April 1, 2022 
	20,940,000
	None

	7.74% Series due July 1, 2002 
	179,000,000
	None

	8 1/2% Series due July 1, 2022 
	90,000,000
	None

	Environmental Series C due December 1, 2022
	25,120,000
	None

	6% Series due March 1, 2000
	100,000,000
	None

	Environmental Series D due May 1, 2023
	34,364,000
	None

	Environmental Series E due December 1, 2023
	25,991,667
	None

	Environmental Series F due July 1, 2024
	21,335,000
	None

	Collateral Series 1994-A, due July 2, 2017
	117,805,000
	None

	Collateral Series 1994-B, due July 2, 2017
	58,865,000
	None

	Collateral Series 1994-C, due July 2, 2017 
	31,575,000
	None

	8 3/4% Series due March 1, 2026 
	115,000,000
	None

	6 1/2% Series due March 1, 2008 
	115,000,000
	None

	5.80% Series due March 1, 2002 
	75,000,000
	None

	Environmental Series G due June 1, 2030 
	67,200,000
	None

	8 1/2% Series due June 1, 2003 
	150,000,000
	None

	7.60% Series due April 1, 2032 
	150,000,000
	None

	5.5% Series due April 1, 2019 
	100,000,000
	None

	6.4% Series due October 1, 2034 
	70,000,000
	None

	5.09% Series due November 1, 2014
	115,000,000
	None

	4.67% Series due June 1, 2010 
	55,000,000
	None

	5.56% Series due September 1, 2015 
	100,000,000
	None

	6.3% Series due September 1, 2035 
	100,000,000
	None

	
			
	5.83% Series due November 1, 2010 
	150,000,000
	None

	6.50% Series due September 1, 2018
	300,000,000
	300,000,000

	5.40% Series due November 1, 2024
	400,000,000
	400,000,000

	6.0% Series due March 15, 2040
	150,000,000
	118,000,000

	4.44% Series due January 15, 2026
	250,000,000
	250,000,000

	Environmental Series H due June 1, 2030 
	119,073,000
	None

	5.875% Series due June 15, 2041
	150,000,000
	150,000,000

	4.80% Series due May 1, 2021
	200,000,000
	200,000,000

	1.1007% Series due December 31, 2012
	750,000,000
	None

	1.875% Series due December 15, 2014
	250,000,000
	None

	5.25% Series due July 1, 2052
	200,000,000
	200,000,000

	3.30% Series due December 1, 2022
	200,000,000
	200,000,000

	4.70% Series due June 1, 2063
	100,000,000
	100,000,000

	4.05% Series due September 1, 2023
	325,000,000
	325,000,000

	5% Series due July 15, 2044
	170,000,000
	170,000,000

	3.78% Series due April 1, 2025
	190,000,000
	190,000,000

	4.95% Series due January 15, 2045
LPFA 2016A Series due 2028
LPFA 2016B Series due 2030
	450,000,000
85,681,000
117,852,000
	450,000,000
85,681,000
117,852,000

	3.25% Series due April 1, 2028
	255,000,000
	255,000,000

	Waterford Series due 2017
	51,971,593.98
	46,516,593.98

	 
	 
	 

which bonds are also hereinafter sometimes called bonds of the First through Eighty-ninth Series, respectively; and
WHEREAS, Section 8 of the Mortgage provides that the form of each series of bonds (other than the First Series) issued thereunder and of the coupons to be attached to coupon bonds of such series shall be established by Resolution of the Board of Directors of the Company and that the form of such series, as established by said Board of Directors, shall specify the descriptive title of the bonds and various other terms thereof, and may also contain such provisions not inconsistent with the provisions of the Mortgage as the Board of Directors may, in its discretion, cause to be inserted therein expressing or referring to the terms and conditions upon which such bonds are to be issued and/or secured under the Mortgage; and
WHEREAS, Section 120 of the Mortgage provides, among other things, that without the consent of any holders of bonds, the Company and the Trustee, at any time and from time to time, may enter into one or more supplemental indentures, in form satisfactory to the Trustee, in order to establish the form and terms of bonds of any series; and
WHEREAS, the Company now desires to create a new series of bonds and establish the terms of bonds of such series; and
WHEREAS, the execution and delivery by the Company of this Eighty-sixth Supplemental Indenture, and the terms of the bonds of the Ninetieth Series, hereinafter referred to, have been duly authorized by the Board of Directors of the Company by appropriate Resolutions of said Board of Directors;
NOW, THEREFORE, THIS INDENTURE WITNESSETH: That the Company, in consideration of the premises and of One Dollar to it duly paid by the Trustee at or before the ensealing and delivery of these presents, the receipt whereof is hereby acknowledged, and in further evidence of assurance of the estate, title and rights of the Trustee and in order further to secure the payment both of the principal of and interest and premium, if any, on the bonds from time to time issued under the Mortgage, according to their tenor and 

effect, and the performance of all the provisions of the Mortgage (including any instruments supplemental thereto and any modification made as in the Mortgage provided) and of said bonds, hereby grants, bargains, sells, releases, conveys, assigns, transfers, mortgages, hypothecates, affects, pledges, sets over and confirms (subject, however, to Excepted Encumbrances as defined in Section 6 of the Mortgage, as supplemented) unto The Bank of New York Mellon, as Trustee under the Mortgage, as supplemented, and to its successor or successors in said trust, and to said Trustee and its successors and assigns forever, (a) all of the Mortgaged and Pledged Property acquired by the Company from the Predecessor Company pursuant to the 2015 Transfer Documents, and improvements, extensions and additions thereto and renewals and replacements thereof, (b) the property made and used by the Company as the basis under any of the provisions of the Mortgage, as supplemented, for the authentication and delivery of additional bonds or the withdrawal of cash or the release of property, and (c) such franchises, repairs and additional property as may be acquired, made or constructed by the Company (1) to maintain, renew and preserve the franchises covered by this Mortgage, as supplemented, or (2) to maintain the property mortgaged and intended to be mortgaged under the Mortgage, as supplemented, as an operating system or systems in good repair, working order and condition, or (3) in rebuilding or renewal of property, subject to the Lien of the Mortgage, as supplemented, damaged or destroyed, or (4) in replacement of or substitution for machinery, apparatus, equipment, frames, towers, poles, wire, pipe, tools, implements and furniture, subject to the Lien of the Mortgage, as supplemented, which shall have become old, inadequate, obsolete, worn out, unfit, unadapted, unserviceable, undesirable or unnecessary for use in the operation of the property mortgaged and intended to be mortgaged under the Mortgage, as supplemented.
PROVIDED THAT the following are not and are not intended to be now or hereafter granted, bargained, sold, released, conveyed, assigned, transferred, mortgaged, hypothecated, affected, pledged, set over or confirmed hereunder and are hereby expressly excepted from the lien and operation of this Eighty-sixth Supplemental Indenture and Mortgage, as supplemented, and from the lien and operation of the Mortgage, namely: (1) cash, shares of stock, bonds, notes and other obligations and other securities not hereafter specifically pledged, paid, deposited, delivered or held under the Mortgage or covenanted so to be; (2) merchandise, equipment, materials or supplies held for the purpose of sale in the usual course of business and fuel, oil and similar materials and supplies consumable in the operation of any properties of the Company; rolling stock, buses, motor coaches, automobiles and other vehicles and all aircraft; (3) bills, notes and accounts receivable, judgments, demands and choses in action, and all contracts, leases and operating agreements not specifically pledged under the Mortgage or covenanted so to be; (4) the last day of the term of any lease or leasehold which may hereafter become subject to the lien of the Mortgage; (5) electric energy, gas, ice, and other materials or products generated, manufactured, produced or purchased by the Company for sale, distribution or use in the ordinary course of its business; all timber, minerals, mineral rights and royalties; (6) the Company’s franchise to be a corporation; and (7) any property heretofore released pursuant to any provisions of the Mortgage; provided, however, that the property and rights expressly excepted from the lien and operation of the Mortgage in the above subdivisions (2) and (3) shall (to the extent permitted by law) cease to be so excepted in the event and as of the date that the Trustee or its successor or successors in said trust or a receiver or trustee shall enter upon and take possession of the Mortgaged and Pledged Property in the manner provided in Article XIII of the Mortgage by reason of the occurrence of a Default as defined in Section 65 thereof.
TO HAVE AND TO HOLD all such properties, real, personal and mixed, granted, bargained, sold, released, conveyed, assigned, transferred, mortgaged, hypothecated, affected, pledged, set over or confirmed by the Company as aforesaid, or intended so to be, unto The Bank of New York Mellon, as Trustee, and its successors and assigns forever.
IN TRUST NEVERTHELESS, for the same purposes and upon the same terms, trusts and conditions 

and subject to and with the same provisos and covenants as are set forth in the Mortgage, as supplemented, this Eighty-sixth Supplemental Indenture being supplemental thereto.
AND IT IS HEREBY COVENANTED by the Company that all the terms, conditions, provisos, covenants and provisions contained in the Mortgage, as supplemented, shall affect and apply to the property hereinbefore described and conveyed and to the estate, rights, obligations and duties of the Company and the Trustee and the beneficiaries of the trust with respect to said property, and to the Trustee and its successors as Trustee of said property in the same manner and with the same effect as if said property had been owned by the Florida Company at the time of the execution of the Mortgage, and had been specifically and at length described in and conveyed to said Trustee by the Mortgage as a part of the property therein stated to be conveyed.
The Company further covenants and agrees to and with the Trustee and its successor or successors in said trust under the Mortgage as follows:
ARTICLE I
NINETIETH SERIES BONDS

SECTION 1.    There shall be a series of bonds designated "4.875% Series due September 1, 2066” (herein sometimes called the “Ninetieth Series”), each of which shall also bear the descriptive title “First Mortgage Bond”, and the form thereof, which has been established by Resolution of the Board of Directors of the Company, is attached hereto as Exhibit A. Bonds of the Ninetieth Series (which shall be initially issued in the aggregate principal amount of $70,000,000) shall be dated as in Section 10 of the Mortgage provided, shall mature on September 1, 2066, shall be issued as fully registered bonds in any integral multiple or multiples of Twenty-five Dollars, and shall bear interest at the rate of 4.875% per annum, the first interest payment to be made on December 1, 2016, for the period from August 17, 2016 to December 1, 2016 with subsequent interest payments payable quarterly on March 1, June 1, September 1 and December 1 of each year (each, an “Interest Payment Date”), the principal of and interest on each said bond to be payable at the office or agency of the Company in the Borough of Manhattan, The City of New York, in such coin or currency of the United States of America as at the time of payment is legal tender for public and private debts. Interest on the bonds of the Ninetieth Series shall be paid to the Person in whose name such bonds of the Ninetieth Series are registered.

Interest on the bonds of the Ninetieth Series will be computed on the basis of a 360-day year of twelve 30-day months.  In any case where any Interest Payment Date, redemption date or the maturity date of any bond of the Ninetieth Series shall not be a Business Day, then payment of interest or principal and premium, if any, need not be made on such date, but may be made on the next succeeding Business Day, with the same force and effect, and in the same amount, as if made on the corresponding Interest Payment Date, redemption date, or at maturity, as the case may be, and, if such payment is made or duly provided for on such Business Day, no interest shall accrue on the amount so payable for the period from and after such Interest Payment Date, redemption date or the maturity date, as the case may be, to such Business Day.  “Business Day” means any day, other than a Saturday or a Sunday, or a day on which banking institutions in The City of New York are authorized or required by law or executive order to remain closed or a day on which the corporate trust office of the Trustee is closed for business.
The bonds of the Ninetieth Series shall be issued by the Company, registered in the name of and delivered to The Bank of New York Mellon, as trustee (together with its successors as trustee under the Collateral Trust Mortgage referenced below, the “Collateral Trust Trustee”) under the Mortgage and Deed of Trust of the Company dated as of November 1, 2015 as the same may be supplemented and amended from time to time (the “Collateral Trust Mortgage”), to provide for the payment when due (whether at maturity, 

by acceleration or otherwise) of the principal and interest of the Securities (as defined in the Collateral Trust Mortgage) to be issued from time to time under the Collateral Trust Mortgage.
Any payment by the Company under the Collateral Trust Mortgage of the principal of or interest on the Securities which shall have been authenticated and delivered under the Collateral Trust Mortgage on the basis of the issuance and delivery to the Collateral Trust Trustee of bonds of the Ninetieth Series (other than by application of the proceeds of a payment in respect of such bonds) shall, to the extent of such payment, be deemed to satisfy and discharge the obligation of the Company, if any, to make a payment of principal of,  or interest on such bonds, as the case may be, which is then due. 
The Trustee may conclusively presume that the obligation of the Company to pay the principal of and interest on the bonds of the Ninetieth Series as the same shall become due and payable shall have been fully satisfied and discharged unless and until it shall have received a written notice from the Collateral Trust Trustee signed by its President, a Vice President, an Assistant Vice President or a Trust Officer, stating that interest or principal due and payable on any Securities issued under the Collateral Trust Mortgage has not been fully paid and specifying the amount of funds required to make such payment. 
(I) Each holder of a bond of the Ninetieth Series consents that the bonds of the Ninetieth Series may be redeemed at the option of the Company or pursuant to the requirements of the Mortgage in whole at any time, or in part from time to time, prior to maturity, without notice provided in Section 52 of the Mortgage, at the principal amount of the bonds to be redeemed, in each case, together with accrued interest to the date fixed for redemption by the Company in a notice delivered to the Trustee and to the holder of the bonds to be redeemed on or before the date fixed for redemption.
The bonds of the Ninetieth Series shall be redeemed, in whole at any time, or in part from time to time, prior to maturity, at a redemption price equal to the principal amount thereof, upon receipt by the Trustee of a written notice from the Collateral Trust Trustee (i) delivered to the Trustee and the Company, (ii) signed by its President, a Vice President, an Assistant Vice President or a Trust Officer, (iii) stating that an Event of Default has occurred and is continuing under the Collateral Trust Mortgage and that, as a result, there then is due and payable a specified amount with respect to the Securities Outstanding under the Collateral Trust Mortgage, for the payment of which the Collateral Trust Trustee has not received funds, and (iv) specifying the principal amount of the bonds of the Ninetieth Series to be redeemed.  Delivery of such notice shall constitute a waiver by the Collateral Trust Trustee of notice of redemption under the Mortgage. 
(II) The bonds of the Ninetieth Series shall not be transferable by the Collateral Trust Trustee, except to a successor trustee under the Collateral Trust Mortgage.  Bonds of this series so transferable to a successor trustee under the Collateral Trust Mortgage may be transferred by the registered owner thereof, in person, or by his duly authorized attorney, at the office or agency of the Company in the Borough of Manhattan, The City of New York, in the manner prescribed in the Mortgage.  
At the option of the registered owner, any bonds of the Ninetieth Series, upon surrender thereof for cancellation at the office or agency of the Company in the Borough of Manhattan, The City of New York, shall be exchangeable for a like aggregate principal amount of bonds of the Ninetieth Series of other authorized denominations.
Upon any exchange or transfer of bonds of the Ninetieth Series, the Company may make a charge therefor sufficient to reimburse it for any tax or taxes or other governmental charge, as provided in Section 12 of the Mortgage, but the Company hereby waives any right to make a charge in addition thereto for any exchange or transfer of bonds of said Series.

(III) Upon the delivery of this Eighty-sixth Supplemental Indenture and upon compliance with the applicable provisions of the Mortgage, as heretofore supplemented, there shall be an initial issue of bonds of the Ninetieth Series for the aggregate principal amount of $70,000,000.  Additional bonds of the Ninetieth Series, without limitation as to amount, having substantially the same terms as the Outstanding bonds of the Ninetieth Series (except for the issue date and, if applicable, the initial Interest Payment Date) may be issued by the Company, subject to satisfaction of the requirements of the Mortgage, as heretofore supplemented, without notice to or the consent of the existing holders of the bonds of the Ninetieth Series.
ARTICLE II

CONSENT TO AMENDMENTS
SECTION 1.    Each initial and future holder of bonds of the Ninetieth Series, by its acquisition of an interest in such Bonds, irrevocably (a) consents to the amendment set forth in Sections 1, 2, 3, 4 and 5 of Article II of the Eighty-first Supplemental Indenture without any other or further action by any holder of such bonds, and (b) designates the Trustee, and its successors, as its proxy with irrevocable instructions to vote and deliver written consents on behalf of such holder in favor of such amendments at any bondholder meeting, in lieu of any bondholder meeting, in any consent solicitation or otherwise.

ARTICLE III
MISCELLANEOUS PROVISIONS
SECTION 1.    Subject to any amendments provided for in this Eighty-sixth Supplemental Indenture, the terms defined in the Mortgage, as heretofore supplemented, shall, for all purposes of this Eighty-sixth Supplemental Indenture, have the meanings specified in the Mortgage, as heretofore supplemented.

SECTION 2.    So long as any bonds of the Ninetieth Series shall remain Outstanding, in each Net Earning Certificate made pursuant to Section 7 of the Mortgage there shall be included in operating expenses for the twelve (12) months period with respect to which such certificate is made an amount, if any (not otherwise included), equal to the provisions for amortization of any amounts included in utility plant acquisition adjustment accounts for such period. 

SECTION 3.    So long as any bonds of the Ninetieth Series shall remain Outstanding, subdivision (2) of Section 7(A) of the Mortgage is hereby amended by adding thereto the following words “provided, further, that the amount so included in such operating expenses in lieu of the amounts actually appropriated out of income for retirement of the Mortgaged and Pledged Property used primarily and principally in the electric, gas, steam and/or hot water utility business and the Company’s automotive equipment used in the operation of such property shall not be less than the amounts so actually appropriated out of income”.

SECTION 4.    The Trustee hereby accepts the trusts herein declared, provided, created or supplemented and agrees to perform the same upon the terms and conditions herein and in the Mortgage, as heretofore amended, set forth and upon the following terms and conditions: 

The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Eighty-sixth Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made by the Company solely. In general, each and every term and condition contained in Article XVII of the Mortgage, as heretofore amended, shall apply to and form part of this Eighty-sixth Supplemental Indenture with the same force and effect as if the same were herein set forth in full with such omissions, variations and insertions, if any, as may be appropriate to make the same conform to the provisions of this Eighty-sixth Supplemental Indenture.

SECTION 5.    Whenever in this Eighty-sixth Supplemental Indenture any of the parties hereto is named or referred to, this shall, subject to the provisions of Articles XVI and XVII of the Mortgage, as heretofore amended, be deemed to include the successors and assigns of such party, and all covenants and agreements in this Eighty-sixth Supplemental Indenture contained by or on behalf of the Company, or by or on behalf of the Trustee, shall, subject as aforesaid, bind and inure to the respective benefits of the respective successors and assigns of such parties, whether so expressed or not. 

SECTION 6.    Nothing in this Eighty-sixth Supplemental Indenture, expressed or implied, is intended, or shall be construed, to confer upon, or give to, any person, firm or corporation, other than the parties hereto and the holders of the bonds and coupons Outstanding under the Mortgage, any right, remedy or claim under or by reason of this Eighty-sixth Supplemental Indenture or any covenant, condition, stipulation, promise or agreement hereof, and all the covenants, conditions, stipulations, promises and agreements in this Eighty-sixth Supplemental Indenture contained by or on behalf of the Company shall be for the sole and exclusive benefit of the parties hereto, and of the holders of the bonds and coupons Outstanding under the Mortgage. 

SECTION 7.    It is the intention and it is hereby agreed that, so far as concerns that portion of the Mortgaged and Pledged Property situated within the State of Louisiana, the general language of conveyance contained in this Eighty-sixth Supplemental Indenture is intended and shall be construed as words of hypothecation and not of conveyance, and that, so far as the said Louisiana property is concerned, this Eighty-sixth Supplemental Indenture shall be considered as an act of mortgage and pledge under the laws of the State of Louisiana, and the Trustee herein named is named as mortgagee and pledgee in trust for the benefit of itself and of all present and future holders of bonds and coupons issued and to be issued under the Mortgage, and is irrevocably appointed special agent and representative of the holders of the bonds and coupons issued and to be issued under the Mortgage and vested with full power in their behalf to effect and enforce the mortgage and pledge hereby constituted for their benefit, or otherwise to act as herein provided for. 

SECTION 8.    This Eighty-sixth Supplemental Indenture shall be executed in several counterparts, each of which shall be an original and all of which shall constitute but one and the same instrument.

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

IN WITNESS WHEREOF, ENTERGY LOUISIANA, LLC has caused its company name to be hereunto affixed, and this instrument to be signed and sealed by its President or one of its Vice Presidents, its Treasurer or one of its Assistant Treasurers, and its company seal to be attested by its Secretary or one of its Assistant Secretaries, for and in its behalf, and THE BANK OF NEW YORK MELLON, in token of its acceptance of the trust hereby created, has caused its corporate name to be hereunto affixed, and this instrument to be signed and sealed by one of its Vice Presidents, Senior Associates or Associates and its corporate seal to be attested by one of its Vice Presidents, Senior Associates or Associates, all as of the day and year first above written.
	
		
	 
	ENTERGY LOUISIANA, LLC

By:  /s/ Stacey M. Lousteau
Name: Stacey M. Lousteau
Title:   Assistant Treasurer

	Attest:

By: /s/ Dawn A. Balash
Name: Dawn A. Balash
Title:   Assistant Secretary
	 

	Executed, sealed and delivered by
ENTERGY LOUISIANA, LLC
in the presence of:

/s/ Leah W. Dawsey
Name: Leah W. Dawsey

/s/ Christina M. Edwards
Name: Christina M. Edwards
	 

	
		
	 
	THE BANK OF NEW YORK MELLON
As Successor Trustee

By:  /s/ Laurence J. O’Brien
Name: Laurence J. O’Brien
Title:   Vice President

	Attest:

By: /s/ Latoya S. Elvin
Name: Latoya S. Elvin
Title:  Vice President
	 

	Executed, sealed and delivered by
THE BANK OF NEW YORK MELLON
in the presence of:

/s/ John Bowman
Name: John Bowman

/s/ Marcela Alvarez
Name: Marcela Alvarez
	 

STATE OF LOUISIANA
                                                    } ss.:
PARISH OF ORLEANS
On this 15th day of August, 2016, before me appeared STACEY M. LOUSTEAU, to me personally known, who, being by me duly sworn, did say that she is Assistant Treasurer of ENTERGY LOUISIANA, LLC, and that the seal affixed to the above instrument is the seal of said entity and that said instrument was signed and sealed in behalf of said entity by authority of its Board of Directors, and said STACEY M. LOUSTEAU, acknowledged said instrument to be the free act and deed of said entity.
On this 15th day of August, 2016, before me personally came STACEY M. LOUSTEAU, to me known, who, being by me duly sworn, did depose and say that she resides at 1013 Pasadena Avenue, Metairie, LA 70001; that she is Assistant Treasurer of ENTERGY LOUISIANA, LLC, one of the entities described in and which executed the above instrument; that she knows the seal of said entity; that the seal affixed to said instrument is such seal, that it was so affixed by order of the Board of Directors of said entity, and that she signed her name thereto by like order.
	
		
	 
	 

	 
	/s/ Jennifer B. Favalora
Notary Public
Name: Jennifer B. Favalora
Notary ID Number 57639
My commission expires: at my death

            

STATE OF NEW JERSEY
                                                            } ss.:
COUNTY OF PASSAIC
On this 11th day of August, 2016, before me appeared Laurence J. O’Brien, to me personally known or proved to me on the basis of satisfactory evidence and, who, being by me duly sworn, did say that he/she is a Vice President of THE BANK OF NEW YORK MELLON, and that the seal affixed to the above instrument is the corporate seal of said entity and that said instrument was signed and sealed in behalf of said entity by authority of its Board of Directors, and said Vice President acknowledged said instrument to be the free act and deed of said entity.
On this 11th day of August, 2016, before me personally came Latoya S.Elvin, to me known or proved to me on the basis of satisfactory evidence and, who, being by me duly sworn, did depose and say that he/she resides in New York, New York; that he/she is a Vice President of THE BANK OF NEW YORK MELLON, one of the entities described in and which executed the above instrument; that he/she knows the seal of said entity; that the seal affixed to said instrument is such seal, that it was so affixed by order of the Board of Directors of said entity, and that he/she signed his/her name thereto by like order.

/s/ Rick J. Fierro
Rick J. Fierro
Notary Public
State of New Jersey
My Commission Expires Nov 24, 2019

EXHIBIT A

This Bond is not transferable except to a successor trustee under the Collateral Trust Mortgage (as defined below) between Entergy Louisiana, LLC and the Collateral Trust Trustee (as defined below).  This Bond is a Class A Bond (as defined in the Collateral Trust Mortgage) issued under the ELL Mortgage (as defined in the Collateral Trust Mortgage).
(TEMPORARY REGISTERED BOND)
ENTERGY LOUISIANA, LLC
First Mortgage Bond, 4.875% Series due September 1, 2066
                 
TR-    $________
ENTERGY LOUISIANA, LLC, a limited liability company of the State of Texas (hereinafter called the “Company”), for value received, hereby promises to pay to THE BANK OF NEW YORK MELLON, as trustee under the Mortgage and Deed of Trust of the Company dated as of November 1, 2015 (as the same may be supplemented and amended from time to time, the “Collateral Trust Mortgage”), or its successor as trustee under the Collateral Trust Mortgage, on September 1, 2066, at the office or agency of the Company in the Borough of Manhattan, The City of New York,

in such coin or currency of the United States of America as at the time of payment is legal tender for public and private debts, and to pay to the registered owner hereof interest thereon from August 17, 2016, if the date of this bond is prior to December 1, 2016, or if the date of this bond is on or after December 1, 2016, from the March 1, June 1, September 1 or December 1 immediately preceding the date of this bond to which interest has been paid on the bonds of this series (unless the date hereof is an interest payment date to which interest has been paid, in which case from the date hereof), at the rate of 4.875% per annum in like coin or currency at said office or agency on March 1, June 1, September 1 and December 1 of each year, commencing December 1, 2016 until the principal of this bond shall have become due and payable, and to pay interest on any overdue principal and (to the extent that payment of such interest is enforceable under applicable law) on any overdue installment of interest at the rate of 6% per annum.   Interest hereon shall be paid to the Person in whose name this bond is registered.
Interest on the bonds of this series will be computed on the basis of a 360-day year of twelve 30-day months.  In any case where any Interest Payment Date, redemption date or the maturity date of any bond of this series shall not be a Business Day, then payment of interest or principal and premium, if any, need not be made on such date, but may be made on the next succeeding Business Day, with the same force and effect, and in the same amount, as if made on the corresponding Interest Payment Date, redemption date, or at maturity, as the case may be, and, if such payment is made or duly provided for on such Business Day, no interest shall accrue on the amount so payable for the period from and after such Interest Payment Date, redemption date or the maturity date, as the case may be, to such Business Day.  “Business Day” means any day, other than a Saturday or a Sunday, or a day on which banking institutions in The City of New York are authorized or required by law or executive order to remain closed or a day on which the corporate trust office of the Trustee is closed for business.
This bond is a temporary bond and is one of an issue of bonds of the Company issuable in series and is one of a series known as its First Mortgage Bonds, 4.875% Series due September 1, 2066, all bonds of all series issued and to be issued under and equally secured (except insofar as any sinking or other fund, established in accordance 

with the provisions of the Mortgage hereinafter mentioned, may afford additional security for the bonds of any particular series) by the Company’s Mortgage and Deed of Trust (herein, together with any indenture supplemental thereto, including the Eighty-sixth Supplemental Indenture dated as of August 1, 2016, called the “Mortgage”), dated as of April 1, 1944, executed by the Company to The Bank of New York Mellon, successor trustee (the “Trustee”).  Reference is made to the Mortgage for a description of the property mortgaged and pledged, the nature and extent of the security, the rights of the holders of the bonds and of the Trustee in respect thereof, the duties and immunities of the Trustee, the terms and conditions upon which the bonds are and are to be secured, the circumstances under which additional bonds may be issued and the rights of the Company to amend the Mortgage without any consent or other action by the holders of any series of bonds (including this series).  With the consent of the Company and to the extent permitted by and as provided in the Mortgage, the rights and obligations of the Company and/or the rights of the holders of the bonds and/or coupons and/or the terms and provisions of the Mortgage may be modified or altered by such affirmative vote or votes of the holders of bonds then outstanding as are specified in the Mortgage. Each initial and future holder of the bonds of this series, by its acquisition of an interest in such bonds, irrevocably (a) consents to the amendments set forth in Article II of the Eighty-first Supplemental Indenture without any other or further action by any holder of such bonds, and (b) designates the Trustee, and its successors, as its proxy with irrevocable instructions to vote and deliver written consents on behalf of such holder in favor of such amendments at any bondholder meeting, in lieu of any bondholder meeting, in any consent solicitation or otherwise.
The bonds of this series shall be issued by the Company, registered in the name of and delivered to The Bank of New York Mellon, as trustee under the Collateral Trust Mortgage, or its successor as trustee under the Collateral Trust Mortgage (collectively, the “Collateral Trust Trustee”), to provide for the payment when due (whether at maturity, by acceleration or otherwise) of the principal and interest of the Securities (as defined in the Collateral Trust Mortgage) to be issued from time to time under the Collateral Trust Mortgage.
Any payment by the Company under the Collateral Trust Mortgage of the principal of or interest on the Securities which shall have been authenticated and delivered under the Collateral Trust Mortgage on the basis of the issuance and delivery to the Collateral Trust Trustee of bonds of this series (other than by application of the proceeds of a payment in respect of such bonds) shall, to the extent of such payment, be deemed to satisfy and discharge the obligation of the Company, if any, to make a payment of principal of,  or interest on such bonds, as the case may be, which is then due. 
The Trustee may conclusively presume that the obligation of the Company to pay the principal of and interest on this bond as the same shall become due and payable shall have been fully satisfied and discharged unless and until it shall have received a written notice from the Collateral Trust Trustee signed by its President, a Vice President, an Assistant Vice President or a Trust Officer, stating that interest or principal due and payable on any Securities issued under the Collateral Trust Mortgage has not been fully paid and specifying the amount of funds required to make such payment. 
The holder of this bond hereby consents that the bonds of this series may be redeemable at the option of the Company or pursuant to the requirements of the Mortgage in whole at any time, or in part from time to time, prior to the maturity date, without notice provided in Section 52 of the Mortgage, at the principal amount of the bonds to be redeemed, in each case, together with accrued interest to the date fixed for redemption by the Company in a notice delivered to the Trustee and to the holder of the bonds to be redeemed on or before the date fixed for redemption.
The bonds of this series shall be redeemed, in whole at any time, or in part from time to time, prior to the maturity date, at a redemption price equal to the principal amount thereof, upon receipt by the Trustee of a written notice from the Collateral Trust Trustee (i) delivered to the Trustee and the Company, (ii) signed by its President, a Vice President, an Assistant Vice President or a Trust Officer, (iii) stating that an Event of Default has occurred and is continuing under the Collateral Trust Mortgage and that, as a result, there then is due and payable a specified amount with respect to the Securities Outstanding under the Collateral Trust Mortgage, for the payment of which the Collateral Trust Trustee has not received funds, and (iv) specifying the principal amount of the bonds of this series to be redeemed.  Delivery of such notice shall constitute a waiver by the Collateral Trust Trustee of notice of redemption under the Mortgage.

The principal hereof may be declared or may become due prior to the maturity date hereinbefore named on the conditions, in the manner and at the time set forth in the Mortgage, upon the occurrence of a default as in the Mortgage provided.
This bond is not transferable except to any successor trustee under the Collateral Trust Mortgage, any such transfer to be made in the manner prescribed in the Mortgage, by the registered owner hereof in person, or by his duly authorized attorney, at the office or agency of the Company in the Borough of Manhattan, The City of New York, upon surrender and cancellation of this bond, together with a written instrument of transfer whenever required by the Company duly executed by the registered owner or by his duly authorized attorney, and thereupon a new fully registered bond of the same series for a like principal amount will be issued to the transferee in exchange herefor as provided in the Mortgage.  
The Company and the Trustee may deem and treat the person in whose name this bond is registered as the absolute owner hereof for the purpose of receiving payment and for all other purposes and neither the Company nor the Trustee shall be affected by any notice to the contrary.
In the manner prescribed in the Mortgage, any bonds of this series, upon surrender thereof, for cancellation, at the office or agency of the Company in the Borough of Manhattan, The City of New York, are exchangeable for a like aggregate principal amount of bonds of the same series of other authorized denominations.  
Upon any transfer or exchange of bonds of this series, the Company may make a charge therefor sufficient to reimburse it for any tax or taxes or other governmental charge, as provided in Section 12 of the Mortgage, but the Company hereby waives any right to make a charge in addition thereto for any exchange or transfer of bonds of this series. 
In the manner prescribed in the Mortgage, this temporary bond is exchangeable at the office or agency of the Company in the Borough of Manhattan, The City of New York, without charge, for a definitive bond or bonds of the same series of a like aggregate principal amount when such definitive bonds are prepared and ready for delivery.
As provided in the Mortgage, the Company shall not be required to make transfers or exchanges of bonds of any series for a period of ten days next preceding any interest payment date for bonds of said series, or next preceding any designation of bonds of said series to be redeemed, and the Company shall not be required to make transfers or exchanges of any bonds designated in whole or in part for redemption.
No recourse shall be had for the payment of the principal of or interest on this bond against any incorporator or any  past, present or future subscriber to the capital stock, stockholder, officer or director of the Company or of any predecessor or successor corporation, as such, either directly or through the Company or any predecessor or successor corporation, under any rule of law, statute or constitution or by the enforcement of any assessment or otherwise, all such liability of incorporators, subscribers, stockholders, officers and directors being released by the holder or owner hereof by the acceptance of this bond and being likewise waived and released by the terms of the Mortgage.
This bond shall not become obligatory until The Bank of New York Mellon, the Trustee under the Mortgage, or its successor thereunder, shall have signed the form of authentication certificate endorsed hereon.

IN WITNESS WHEREOF, ENTERGY LOUISIANA, LLC has caused this bond to be signed in its company name by its President or one of its Vice Presidents by his or her signature or a facsimile thereof, and its company seal to be impressed or imprinted hereon and attested by its Secretary or one of its Assistant Secretaries by his or her signature or a facsimile thereof.
DATED: ____________                ENTERGY LOUISIANA, LLC

By:__________________________________________            
Vice President and Treasurer
Attest:

________________________________
Assistant Secretary

TRUSTEE’S AUTHENTICATION CERTIFICATE
This bond is one of the bonds, of the series herein designated, described or provided for in the within-mentioned Mortgage.
THE BANK OF NEW YORK MELLON
as Trustee
By:_________________________________________
Authorized Signatory

Dated: ______________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}]]